Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krag

Showing results (1101-1110 of 1,158) with videos related to

Pageof 116
Sort By:
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
Journal of Hepatology|March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesMaja Thiele, Ida Falk Villesen, Lili Niu, et al.
Hepatology (Baltimore, Md.)|March 11, 2026
Original research: Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiencyChristina Schrader, Malin Fromme, Paul Ellis, et al.
The Lancet. Gastroenterology & Hepatology|January 18, 2021
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysisDavid Petroff, Valentin Blank, Philip N Newsome, et al.
Journal of Hepatology|November 28, 2024
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver diseaseJuan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
Use of albumin infusion for cirrhosis-related complications: An international position statementZhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, et al.
Cell|November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associationsSuguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.
Gastroenterology|January 24, 2018
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With CirrhosisMacarena Simón-Talero, Davide Roccarina, Javier Martínez, et al.
The Lancet. Gastroenterology & Hepatology|March 26, 2026
Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysisZobair M Younossi, Aleksander Krag, Shira Zelber-Sagi, et al.
Molecular Syndromology|October 27, 2016
Gene Panel Testing in Epileptic Encephalopathies and Familial EpilepsiesRikke S Møller, Line H G Larsen, Katrine M Johannesen, et al.
Pageof 116

Showing results (1101-1110 of 1,158) with videos related to

Sort By:
Pageof 116
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
Journal of Hepatology|March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesMaja Thiele, Ida Falk Villesen, Lili Niu, et al.
Hepatology (Baltimore, Md.)|March 11, 2026
Original research: Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiencyChristina Schrader, Malin Fromme, Paul Ellis, et al.
The Lancet. Gastroenterology & Hepatology|January 18, 2021
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysisDavid Petroff, Valentin Blank, Philip N Newsome, et al.
Journal of Hepatology|November 28, 2024
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver diseaseJuan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
Use of albumin infusion for cirrhosis-related complications: An international position statementZhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, et al.
Cell|November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associationsSuguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.
Gastroenterology|January 24, 2018
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With CirrhosisMacarena Simón-Talero, Davide Roccarina, Javier Martínez, et al.
The Lancet. Gastroenterology & Hepatology|March 26, 2026
Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysisZobair M Younossi, Aleksander Krag, Shira Zelber-Sagi, et al.
Molecular Syndromology|October 27, 2016
Gene Panel Testing in Epileptic Encephalopathies and Familial EpilepsiesRikke S Møller, Line H G Larsen, Katrine M Johannesen, et al.
Pageof 116